Combination of two immunotherapies shows activity in non-small cell lung cancer patients

A combination of two drugs, which prompt the body's immune system to identify and kill cancer cells, is a safe treatment for patients with advanced non-small cell lung cancer and has shown some signs of efficacy. The research is presented at the 30th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

EORTC [+]    NCI [+]    AACR [+]    Dublin [+]    Ireland [+]   

More #news: